60
Participants
Start Date
April 27, 2021
Primary Completion Date
April 5, 2026
Study Completion Date
April 5, 2026
Intra-nasal Dexmedetomidine
Subjects will receive Dexmedetomidine intra-nasally in the preoperative area. It will be administered at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room.
Oral Midazolam
Subjects will receive Midazolam orally in the preoperative area. It will be administered at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room.
University of Massachusetts Medical School, Worcester
University of Massachusetts, Worcester
OTHER